NCT04914312View on ClinicalTrials.gov

Maqui Berry Extract and Omega-3 Fatty Acids for Cytokine Reduction

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

January 15, 2022

Primary Completion Date

July 30, 2023

Study Completion Date

August 15, 2023

Conditions
Inflammation
Interventions
DIETARY_SUPPLEMENT

Maqui berry/omeg-3 fatty acids

2 capsules BID per day containing a total of 600 mg of Maqui extract; 4 capsules per day supplying a total of 2000 mg EPA and 1000 mg DHA

DIETARY_SUPPLEMENT

Placebos

4 olive oil soft gelatin capsules and inert two-piece capsules containing maltodextrin

Trial Locations (1)

85004

Arizona State University, Phoenix

All Listed Sponsors
lead

Arizona State University

OTHER